在自闭症谱系障碍中使用普拉诺洛的潜在用途:叙述性审查
Lorena Francés Soriano1,2, Aina Iglesias Huguet1,2, Juana María Andrés Tauler1,2
1Hospital Universitario Son Espases, Palma de Mallorca, Spain.
Journal of psychopharmacology (Oxford, England)
|December 29, 2025
概括
普罗巴诺洛尔可以帮助管理自闭症谱系障碍 (ASD) 症状,如焦虑和行为问题,通过影响神经系统. 需要更多的研究来确认其在ASD患者长期使用的有效性和安全性.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 精神病学是一个精神病学.
背景情况:
- 自闭症谱系障碍 (ASD) 在社交沟通和行为方面存在挑战.
- 目前对ASD核心特征的治疗方法有限.
- 作为β-阻断剂的普罗普拉诺洛尔在ASD中显示出潜在的治疗效果.
研究的目的:
- 审查现有证据,以证明普拉诺洛尔对ASD核心和相关症状的疗效.
- 探索普拉拉诺洛尔在ASD中的潜在作用机制.
- 确定当前研究中的差距,并建议未来的方向.
主要方法:
- 一个依据PRISMA指南的叙事审查.
- 在主要数据库 (PubMed,Scopus,ScienceDirect,ProQuest) 进行系统的文献搜索.
- 包括22项已识别的研究中的15项研究,包括RCT,挑战性研究和评论.
主要成果:
- 普罗巴诺洛尔可以改善社交焦虑,认知灵活性和ASD的情绪/行为调节.
- 潜在的机制包括减弱上腺激素过度兴奋和促进副交感活动.
- 证据主要基于小样本或单剂量研究;持续释放,双盲试验很少.
结论:
- 普罗普拉诺洛尔作为选择性ASD病例的辅助疗法具有前景,特别是在焦虑症状方面.
- 它的中枢神经系统透和焦虑缓解特性需要进一步研究.
- 生物标志物和药物遗传学可以指导未来试验中的个性化治疗选择.
相关概念视频
Autism Spectrum Disorder
892
Autism spectrum disorder (ASD) is a neurodevelopmental condition marked by persistent deficits in social communication and interaction alongside restrictive and repetitive behaviors or interests. ASD is sometimes accompanied by intellectual impairment.
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.
892
Modeling in Therapy
360
Modeling, a key technique in therapy, uses observational learning to help clients acquire and practice new skills by watching therapists demonstrate desired behaviors. This approach, rooted in Albert Bandura's concept of vicarious learning, plays a significant role in therapeutic interventions for various psychological conditions, including social anxiety, ADHD, and depression.
Participant Modeling
Participant modeling involves therapists demonstrating calm and effective behaviors in...
Participant Modeling
Participant modeling involves therapists demonstrating calm and effective behaviors in...
360
Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers
1.5K
β-receptor blockers significantly impact the cardiovascular system by counteracting catecholamine-induced sympathetic responses. These medications decrease heart rate, contractility, and cardiac output, potentially leading to cardiac depression, life-threatening bradycardia, and death. Therapeutically, β-blockers function as mild antihypertensives and are utilized in treating angina pectoris and cardiac arrhythmias. However, nonselective β-blockers inhibit β2-receptors in...
1.5K
Operant Conditioning Intervention
426
Operant conditioning serves as a foundational principle in therapeutic interventions aimed at modifying maladaptive behaviors. Central to this approach is the notion that behaviors, both adaptive and maladaptive, are learned through reinforcement. By analyzing the environmental factors that reinforce problematic behaviors, clinicians can design interventions to weaken these reinforcements and replace maladaptive behaviors with healthier alternatives.
In operant conditioning, behaviors that are...
In operant conditioning, behaviors that are...
426
Behavior Modification
513
Behavioral approaches have often been criticized for ignoring mental processes and focusing solely on observable behavior. However, these approaches provide an optimistic perspective for individuals seeking to change their behaviors. Rather than concentrating on intrinsic personality traits, behavioral approaches suggest that even longstanding habits can be modified by changing the reward contingencies that maintain them.
A real-world application of operant conditioning principles is applied...
A real-world application of operant conditioning principles is applied...
513


